U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419698) titled 'Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants' on Feb. 12.
Brief Summary: A This is a single-center, randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical trial. It aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single administration of JMT206 Injection in healthy participants.
Study Start Date: Jan. 26
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
BIOLOGICAL: JMT206
Subcutaneous injection, single dose.
DRUG: Placebo
Subcutaneous injection, single dose.
Recruitment Status: RECRUITING
Spon...